These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ethacrynic acid: assessment of saluretic and diuretic potency in patients with severe chronic renal failure. Edwards KD; Sinnett PF; Stewart JH Med J Aust; 1967 Feb; 1(8):375-81. PubMed ID: 6021236 [No Abstract] [Full Text] [Related]
4. [Effects of potent diuretics in renal failure]. Kawaguchi Y; Sakai S; Yamamoto M; Tanaka S; Oda Y Nihon Rinsho; 1974 Aug; 32(8):2636-43. PubMed ID: 4612209 [No Abstract] [Full Text] [Related]
5. Renal function and diuretic therapy in infants and children. Part III. Loggie JM; Kleinman LI; Van Maanen EF J Pediatr; 1975 Jun; 86(6):825-32. PubMed ID: 1127522 [No Abstract] [Full Text] [Related]
6. Diuretics in chronic renal disease: a study of high dosage frusemide. Allison ME; Kennedy AC Clin Sci; 1971 Sep; 41(3):171-87. PubMed ID: 5571498 [No Abstract] [Full Text] [Related]
9. The potassium-sparing effect of amiloride hydrochloride (MK-870) on the kaliuretic effect of ethacrynic acid. Sethy VH; Patel DG; Doshi JC; Mehta JM; Sheth UK J Clin Pharmacol J New Drugs; 1968; 8(5):309-14. PubMed ID: 5244660 [No Abstract] [Full Text] [Related]
10. The use of diuretics in varying degrees of renal impairment: an overview. Lowenthal DT; Dickerman D Clin Exp Hypertens A; 1983; 5(2):297-307. PubMed ID: 6403264 [TBL] [Abstract][Full Text] [Related]
11. [Renal excretion of calcium in chronic renal insufficiency]. Raszeja-Wanic B; Gluszek J; Smarsz C; Wachowiak A Pol Arch Med Wewn; 1973 Nov; 50(11):1181-7. PubMed ID: 4768249 [No Abstract] [Full Text] [Related]
12. Diuretic effects of Bay g 2821 in patients with advanced renal failure. Röckel A Curr Med Res Opin; 1977; 4(8):574-9. PubMed ID: 406116 [TBL] [Abstract][Full Text] [Related]
13. Effect of ibopamine on the progression of chronic renal failure. Docci D; Pistocchi E; Turci F; Baldrati L Clin Nephrol; 1986 Sep; 26(3):121-4. PubMed ID: 3769226 [TBL] [Abstract][Full Text] [Related]
14. Diuretics. II. Clinical considerations. Anderton JL; Kincaid-Smith P Drugs; 1971; 1(2):141-65. PubMed ID: 4939014 [No Abstract] [Full Text] [Related]
15. [Comparative evaluation of the effect of diuretics in renal diseases]. Lao M; Zaleski A Pol Arch Med Wewn; 1970 Jun; 44(6):659-66. PubMed ID: 5449807 [No Abstract] [Full Text] [Related]
16. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Ford ML; Tomlinson LA; Chapman TP; Rajkumar C; Holt SG Hypertension; 2010 May; 55(5):1110-5. PubMed ID: 20212269 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of amiloride, a potassium-sparing diuretic. Lant AF; Smith AJ; Wilson GM Clin Pharmacol Ther; 1969; 10(1):50-63. PubMed ID: 4884296 [No Abstract] [Full Text] [Related]
18. Acute renal effects of high doses of furosemide administered intravenously in patients with advanced chronic renal insufficiency. Radò JP; Juhos E; Szende L; Marosi J; Takò J; Salamon F J Med; 1973; 4(4):219-32. PubMed ID: 4520349 [No Abstract] [Full Text] [Related]
19. Hypertension in end-stage renal disease. Vertes V; Cangiano JL; Berman LB; Gould A N Engl J Med; 1969 May; 280(18):978-81. PubMed ID: 5781668 [No Abstract] [Full Text] [Related]